Stock comparison
Bio-Rad Laboratories
BIO$9.16BHealthcare Market cap, Sector
Sanofi Consumer Healthcare India Limited
SANOFICONR.BO$104.98BHealthcare Market cap, Sector
Overall winner
Sanofi Consumer Healthcare India Limited
BIO 07 SANOFICONR.BO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
BIO0wins
7winsSANOFICONR.BO
41F
B78
46D
A89
28F
B83
8F
B77
40F
A91
32F
A86
24F
A85
Side-by-side metrics
| Metric | BIO | SANOFICONR.BO |
|---|---|---|
| Market cap | $9.16B | $104.98B Winner |
| P/E (TTM) | Winner: 39.5x | 44.0x |
| EV/EBIT | Winner: 28.0x | 31.7x |
| ROIC (TTM) | 1.95% | 59.15% Winner |
| Gross margin | 51.87% | 68.13% Winner |
| Net margin | 6.52% | 27.35% Winner |
| Revenue CAGR 5y | -3.04% | 27.01% Winner |
| EPS CAGR 5y | -33.51% | 20.67% Winner |
| Debt / Equity | 0.2x | 0.1x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BIO leads on
- EV/EBIT28.0xvs 31.7x+12%
- P/E (TTM)39.5xvs 44.0x+10%
SANOFICONR.BO leads on
- EPS CAGR 5y20.67%vs -33.51%+162%
- Revenue CAGR 5y27.01%vs -3.04%+111%
- ROIC (TTM)59.15%vs 1.95%+97%
- Market cap$104.98Bvs $9.16B+91%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.